{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981471421663232.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/sj.bjc.6600696"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/6600696.pdf"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/6600696"}}],"dc:title":[{"@value":"Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380285528947130125","@type":"Researcher","foaf:name":[{"@value":"P Grabowski"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471421663235","@type":"Researcher","foaf:name":[{"@value":"T Kühnel"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471421663233","@type":"Researcher","foaf:name":[{"@value":"F Mühr-Wilkenshoff"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471421663238","@type":"Researcher","foaf:name":[{"@value":"B Heine"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471421663237","@type":"Researcher","foaf:name":[{"@value":"H Stein"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471421663232","@type":"Researcher","foaf:name":[{"@value":"M Höpfner"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471421663234","@type":"Researcher","foaf:name":[{"@value":"C T Germer"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471421663239","@type":"Researcher","foaf:name":[{"@value":"H Scherübl"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00070920"},{"@type":"EISSN","@value":"15321827"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00070920"}],"prism:publicationName":[{"@value":"British Journal of Cancer"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2003-01","prism:volume":"88","prism:number":"1","prism:startingPage":"115","prism:endingPage":"119"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://www.nature.com/articles/6600696.pdf"},{"@id":"http://www.nature.com/articles/6600696"}],"createdAt":"2003-01-29","modifiedAt":"2023-05-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360283690291220736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204684073472","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Immunohistochemical Study of an Anti-apoptotic Protein, Survivin, in Lung Cancer"},{"@language":"ja","@value":"非小細胞肺癌におけるアポトーシス関連遺伝子Ｓｕｒｖｉｖｉｎの発現頻度の免疫組織化学的検討"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680180144768","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"犬の皮膚リンパ腫およびエリテマトーデスにおけるＳｕｒｖｉｖｉｎの発現"},{"@language":"en","@value":"Expression of Survivin on Canine Cutaneous Lymphoma and Lupus Erythematosus"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/sj.bjc.6600696"},{"@type":"CROSSREF","@value":"10.2736/jjvd.17.7_references_DOI_DH6LtmYXgHXhZ8jhKgi7KvqU2V3"},{"@type":"CROSSREF","@value":"10.1007/s00428-012-1343-7_references_DOI_DH6LtmYXgHXhZ8jhKgi7KvqU2V3"},{"@type":"CROSSREF","@value":"10.2482/haigan.49.12_references_DOI_DH6LtmYXgHXhZ8jhKgi7KvqU2V3"}]}